 IRVINE, Calif., Jan. 05, 2021 GLOBE NEWSWIRE -- Tarsus Pharmaceuticals, Inc. NASDAQ: TARS, a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the ICR Conference 2021, being held virtually from January 11-14. In addition to the presentation, the management team will host investor meetings at the conference. 